India is planning to appeal the World Trade Organization ruling that thecountry is not providing a transparent mechanism to protect drug and agricultural product patents adequately (Marketletter September 15). The appeal had to be filed before September 25, noted Commerce Ministry of Trade official K M Chandresekhar, who would not detail the line that India would take in its arguments, since the legalities are still being worked out.
The WTO will take two or three months to decide the appeal, he said, and if it confirms the earlier decision, India would have to consider its next steps. India now offers only process patents, and while it has until 2005 to begin protecting products, an exception for drugs and agricultural products means that coverage must be provided sooner.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze